.

Mary Zutter, M.D.

Mary Zutter, M.D.Assistant Vice Chancellor for Integrative Diagnostics
Director, Tumor-Host Interaction Program, Vanderbilt Ingram Cancer Center
Scientific Director, Human Tissue Acquisition & Pathology Core

A physician-scientist with clinical expertise in pathology and Hematopathology, Dr. Zutter leads the Diagnostic Management Team. Dr. Zutter’s research focuses on the role of cell adhesion molecules in host-tumor interactions. She has been funded continuously from the NIH for over 20 years and her research laboratory is currently supported by two grants from the NCI. Dr. Zutter has published over 75 peer-reviewed manuscripts and has authored over 14 chapters for medical textbooks.

Dr. Zutter graduated from Tulane University Medical School and completed her pathology residency and hematopathology fellowship training at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. She joined the Department of Pathology faculty at Washington University School of Medicine and served on the faculty for 15 years, before joining Vanderbilt University School of Medicine in 2003.

Dr. Zutter was selected for the Executive Leadership in Academic Medicine (ELAM) program.  She also served as the associate editor for a variety of publications, including Cancer Biology and Therapy and Cancer Research.

“I am passionate about harnessing the power of pathology to improve diagnostic accuracy in a world of increasingly complex testing.”


This page was last updated July 30, 2013 and is maintained by